DURAVYU 2.7mg demonstrated an early and sustained improvement in BCVA with a gain of +8.9 letters compared to baseline -– DURAVYU 2.7mg ...
Chronic therapy is essential for PCV patients, even after resolution of pigment epithelial detachment, to prevent recurrence. Faricimab and aflibercept show efficacy in DME, RVO, and nAMD, but not all ...
A study finds that pistachio consumption significantly increases macular pigment optical density, potentially protecting ...